跳转至内容
Merck

SML1244

Sigma-Aldrich

埃非那康唑

≥98% (HPLC)

别名:

(αR,βR)-, α-(2,4-二氟苯基)-β-甲基-4-亚甲基-α-(1H-1,2 ,4-三唑-1-基甲基)-1-哌啶乙醇, KP-103, (2R,3R)-2-(2,4-二氟苯基)-3-(4-亚甲基哌啶-1-基)-1-(1H-1,2,4-三唑-1-基)丁-2-醇

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C18H22F2N4O
分子量:
348.39
分類程式碼代碼:
51111800
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

光學活性

[α]/D -85 to -95°, c = 1 in chloroform

顏色

white to beige

溶解度

DMSO: 20 mg/mL, clear

儲存溫度

−20°C

InChI

1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25,10-24-12-21-11-22-24)16-4-3-15(19)9-17(16)20/h3-4,9,11-12,14,25H,1,5-8,10H2,2H3/t14-,18-/m1/s1

InChI 密鑰

NFEZZTICAUWDHU-RDTXWAMCSA-N

應用

艾氟康唑已用于:
  • 研究其作为外用抗甲真菌病药,对红色毛癣菌和指(趾)间毛癣菌(Trichophyton interdigitale)的治疗作用
  • 研究其作为抗真菌药对指甲裂解物的渗透性
  • 研究其作为抗真菌药对非洲念珠菌(Candida africana)和都柏林念珠菌(Candida dubliniensis)的治疗作用

生化/生理作用

艾氟康唑(efinaconazole)对多种病原体具有抗性,如石膏样毛癣菌、红色毛癣菌和白色念珠菌。它具有抗念珠菌属活性,用于治疗指甲和皮肤念珠菌病。艾氟康唑也具有抗马拉色菌属活性,用于治疗其引起的花斑癣。
艾氟康唑是一种三唑类抗真菌药物,临床上已批准用于治疗指甲真菌(甲癣)。它通过抑制细胞色素 P450 14α-脱甲基酶(甾醇生物合成途径中的一种酶,使得从羊毛甾醇到麦角固醇)来抑制甾醇生物合成。艾氟康唑具有更好的指甲渗透性,因此比其他局部用药更有效,并且与指甲真菌的口服药物一样有效。

象形圖

Health hazard

訊號詞

Warning

危險聲明

危險分類

Repr. 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

William J Jo Siu et al.
Antimicrobial agents and chemotherapy, 57(4), 1610-1616 (2013-01-16)
Onychomycosis is a common fungal nail infection in adults that is difficult to treat. The in vitro antifungal activity of efinaconazole, a novel triazole antifungal, was evaluated in recent clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Candida albicans, common
Gholamreza Shokoohi et al.
Mycoses, 64(7), 771-779 (2021-04-04)
Vulvovaginal candidiasis (VVC) is a common and debilitating long-term illness affecting million women worldwide. This disease is caused mainly by Candida albicans and a lesser extent by other species, including the two phylogenetically closely related pathogens Candida africana and Candida
Keita Sugiura et al.
Journal of fungi (Basel, Switzerland), 7(3) (2021-04-04)
To evaluate the combination effects of anti-onychomycosis drugs, the minimum inhibitory concentrations of topical (efinaconazole, luliconazole, and tavaborole) and oral (itraconazole and terbinafine) drugs for Trichophyton rubrum and Trichophyton interdigitale (8 each, with a total of 16 strains) were determined
Heather Davies-Strickleton et al.
PloS one, 15(2), e0229414-e0229414 (2020-02-29)
Onychomycosis, or fungal nail infection, is a common fungal infection largely caused by dermatophyte fungi, such as Trichophyton rubrum or Trichophyton mentagrophytes, which affects a significant number of people. Treatment is either through oral antifungal medicines, which are efficacious but

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门